SeeThruEquity has issued a company update and price target of $3.53 on shares of BioSig Technologies, Inc. (OTCQB: BSGM). Among other highlights, the SeeThruEquity analyst noted the recent expansion of BioSig’s collaboration agreement with the Mayo Clinic. The expanded technology and clinical development partnership has a 10-year term and includes cash warrants and licensing opportunities as well as joint intellectual property filings. The analyst also noted upcoming catalysts for the company, including BioSig’s plans to submit a 510(k) application for clearance to commercialize the PURE EP™ by the third quarter of 2017, and news that the company aims to up-list to a national exchange, likely the Nasdaq CM, in the fourth quarter of 2017.
For more information, visit www.biosigtech.com
About BioSig Technologies, Inc.
BioSig Technologies is a medical device company developing a proprietary technology platform designed to improve the $4 billion electrophysiology (EP) marketplace. Led by a proven management team and a veteran, independent Board of Directors, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. BioSig’s technology has been developed to address an unmet need in a large and growing market. The PURE EP System is a novel cardiac signal acquisition and display system which is engineered to assist electrophysiologists in clinical decision making during procedures to diagnose and treat patients with abnormal heart rates and rhythms. BioSig’s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia.
NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer